back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 15:29 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
520,000 | |
| Filed 2024-06-18 16:49 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+130,000 vol |
270,000 | |
| Filed 2023-06-26 12:43 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$39,100
+10,000 vol $3.91 each |
||
| Filed 2023-06-26 12:41 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$39,100
+10,000 vol $3.91 each |
||
| Filed 2023-06-26 12:41 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$150,003
+38,364 vol $3.91 each |
507,114 | |
| Filed 2023-04-13 14:16 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+140,000 vol |
140,000 | |
| Filed 2023-04-12 19:46 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
468,750 | ||
| Filed 2023-04-12 19:45 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-12 19:41 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|